HLA-A2 heavy chain and fo-microglobulin were expressed In Escherichla coll, and refolded In the presence of peptldes derived from HIV-1 RT and gag proteins. When recomblnant HLA-A2 molecules were attached to cells lacking Hl A-A2, the cells became susceptible to lysis by HLA-A2 restricted cytotoxic T lymphocyte (CTL) clones speciflc for peptldes derived from RT and gag proteins. Limiting dilutlon analyses of peripheral blood mononuclear cells from HIV-1-lnfected lndividuals showed that the recombinant HLA-A2 peptlde complexes covalently immobilized on microspheres stimulated the development of HLA-A2 peptide-specific CTL. Preformed HtA-peptide complexes may provide an alternative to immunization procedures that depend upon intracellular processing of antigen to elicit T cell responseslntroduction
lntroduction MHC-encoded class I molecules serve as peptlde binding, transport and display proterns on the cerl sunace, and can evoke T cetl responses when recogntzeo bv antlgen-soecrflc receptors on cytotoxrc T lymphocytes (CTL). l'"4HC class I molecules are glycoproteins conststtng oi f'vo non-covalently assoclated polypeptrde chains, a larger or heavy chatn and a smaller or light chain, termed p2-mrcroQlobulrn (1). Human class I molecules have been refolded f rom suounrts proouced in Escherrchra coli in associatron wrth syntnetlc pepttdes (2) . The three-dimenstOnal StrUctures of severat recombtnant complexes, determined by X-ray crystallography (3) , are vrrtually identical to the Structure of the claSS I molecule isolated from human cells (4) . However the MHC protelns produced in E. colido not contatn the ccmprex carbonyorate that is normally attached to asoaragrne 86. The aim of thts rtork is to determtne lf an MHC class I oroiern, speCtfically HLA-A2 (A2), produced in non-glycosylateo form rn E. colr and assembled with svnthetic nonapeotloes can (i) elictt MHC class I expressron on unmoorfied HLA-A2-negative C1R cetts (HLA-8,C) was determtned wirh mAb 887.7-FITC conjugate (doneo line, 887.7 antr.HLA-A,B,C). To adsorb the Ht-A+€ptide comptexes we covalently anached mAb BBMl (antr-pTmicroglobulin) and mAb MA2.1 (antr-HLA-A2,B 1 7) to the cell sur{ace using a heterobifunctronal cross-lrnker (SPDP). Sudace bound mAb-SPDP conjugates were detected using FITC-goat anti-mouse F(ab)r fragments (dasheC line) Adsorption of HLA-A2 peptrde complexes to mAb-coated cetts was shown by an increase in MHC class I expression using mAb 887.7-FITC conlugate (solid line). mAb W6/32 (11) (lgG2a specrfic for HI-A-A,B,C) and PA2.1 (12) (lgG1 specriic for HLA-M ano A2B), both reactrve wrrh natrve Ht-A-A2 complexes, wts detected with goat antr-mouse lg conjugated to horseradish peroxrdase (1 :5000: Amersham) After washing the nitroceilulose was incubated for 1 mrn wrth reagents for ECL immunodetectron (1:1; Amersham) and exposeo to X-ray film. HLA-A2 peptrde concentrations were measureo by mrcro-BCA (bicinchonrntc acid) assay (Pierce, Rockford, lL), uslng BSA as a stanoard:
Covalent attachment of mAb to the cell sur't'ace mAb BBMl (13) (antr-p2-mrcrogiobuiln) and mAb MA2.1 (14) (antr-HLA-A2, 817) were covalently attached to cells usrng a heterobifunctlonal cross-linker, SPDP IMsuqcinimidyl 3-(2-pyridyldithio)propionate, Piercel, as describcd (15) . SPDP (50 pl, 20 mM in ethanol) was added to mAb in PBS, pti 7 2, (1 mg/ml) for 30 min at room temoerature and then dialyzed against PBS Cells (106) were reduceo with 50 pM dithiothrertol for 30 mrn, washed twrce with P8S and incubated wrth 200 pl of mAb-SPDP at 0 5 mg/ml (1 h at room temperature), wasned and sublected to FACS analvsis.
Adsorption of soluble A2-pepttde complexes to mAb precoated cells Cells (106) with covalently attacheo mAb (using SPDP and dithiothreitol, see above) were incubated with 10 pg soluble HLA-A2 peptide complexes in 500 pl PBS for 30 min at 4'C, washed in 10 ml of cold RPMI, counted and adjusted to the appropnate cell number. Flg. 1. Gel lritratron HPLC profiles of HI-A-A2 peptrde complexes. HPLC prolries of Ht-A-M reconstttutton lrom recombrnant healy charn and p2-mrcroglobuiln in associatron wrth (a) HIV-1 Gag-SL9 peptrde 77-€5, SLYNTVATL and (b) HIV-'l RT-lvg peptrde 47G-484, ILKEPVHGV Specrfic brnding of mAb W6/32 and mAb PA2.1 (both specrlically reactrve with nattve HLA-A2 complexes)to HPLC fractions was used to monitor refolded A2-peptrde complexes.
Methods

CTL clones and cell lines
CTL clones from asymptomatic HIV-1 seroposrtive patrents and the corresponding (autologous) Epstein-Barr vrrus-transformed B lymphoblastoid cell lines (B-LCL) were established and marntained as descnbed prevrously (6, 7) . Subiects '115i, 15760 and 16'lJ were previously shown to have srgnrficant gagl.specrfrc CTL actrvify (6 and unpublished). HlA-typrng was performed by the Massachusetts General HospitalTlssue Typing Laboratory usrng standard serologrcal technrques (subject 161J: A2, 43; 87, 860; C3; DR2, DR4: subject 010-115i: A2, A2B; B1a, 852; CwB; DR1,2; DO1 and subyect 15760: A2,844,851; C3; DR11) RPMI 16a0 (Sigma, St Louis, MO) contarning 20 % (vlv) heat-inactivated FCS (Sigma) was supplemented with u-glutamine (2 mM), peniciliin (50 U/ml), streptomycrn (50 Fg/ml) and used for all cell lines.
Gel filtration HPLC of HLA-A2 peptide complexes
Peptides were synthesized at the MIT Bropolymers laboratory. A2 refolding and complex formation was initiated by dilution of the fwo oenatured subunrts in the presence of peptrdes as prevrously oescrtbed (2) . mAb bindtng to HPLC fracilons mAb binorng to HPLC fractrons was used to monrtor refolded A2-peptrde complexes. Samples of HPLC peak fractions (20 trl) were pipetted onto a nitrocellulose filter (Amersham, Santa Clearbrook, lL) and allowed to adsorb for 2 h at room temperature. The membrane was then incubated with 3% BSA in PBS followed by the respective mAb in 50 mM TrisHCl, pH 8, 100 mM NaCl, 0 05% Tween. Specific binding of 
Cytotoxicity assays
The slCr-labeled target ceils (107 cells) lvere washed twrce with cold PBS, incubated with 50 pM drthiotnreitol for 30 min, again washed with cold PBS ano resuspenoed in 200 pl of SPDP-+nAb at 0.5 mg/ml. After 30 min, the cells were washed twice with cold PBS, resuspenoed wrth 10 pg soluble HLA-A2 peptide in 500 pl PBS at 4"C, and after 30 min cells were
washed with cold RPMI and adiusted to 2X10s cetls/ml Cytotoxicity assays were performed in duplicate wtth CTL clones added at effector-to-target ratros (E:T) of 10, 5, 2 5 and 1 25:1 to mAb-A2 peptide-coated slCr-labeled ceils and to peptide-pulsed cells (prerncubated with a peptrde concentration of 1 pg/ml for 30 mrn and *Ettiu-O) After 4 h at 37"C, cetl supernatants were assayed for 51Cr release. Total slCr release was determtned by detergent lysis and percent specif ic lysis was calculated as [(stCr' samole release -Spontaneous release)i(total releaSe -spontaneous release)]x100. Spontaneous release was always <209'. of maxrmal release.
Preparation of silica microspheres (beads) covalently mooiied with HlA-peptide complexes
We prepared silica beads (microspheres, 5 pm dtameter) whose surfaces are covaiently modified with the HLA-A2 peptide complexes using either the RT ot gag nonapeptrdes.
Beginning with commercrally available (Bangs, LocatronU,
Sr(
O6-h tr: r Flg. 3. susceptibilaty ol target cells coareo wln oufified A2-peptide complexes lo lysis by RT-and Ga,q-specilic 9-T! clones. cytotoxrcrtv a"i.vi n"i" ciri,ei out t",in the Gag-Sl9-specrtrc CTL clone D 23 (a_and c; ano ihe Rl'lvg-specriic ClL-rlone 18030 (b) on CIR cerls. precoated wrth mAb and loaded w(fi sotubte A2.oeptrde complexes (c1R-mAd-A2-peptide). as well as.c1R-A2-transfectants pulsed wrth b"pr,o"lCrn-ez + peptroe. I [g/ml). CTL crones were arso tested agarnsr P815 cells and Pgl5-mAb-A2-peptrde as well as K562 and K562' mAO-n2-peptrde. nLe-A2 pepirO! complexes were bound to slCr-labeted larget cetls atter covalent anachmenl oi antl-HLA-A2-specrfic mAb MA2.l (a ano 3) or antr-F2-mrcrogtobutrn-soecrirc mAb BBMl to the cell sudace (c). Background lysrs for both T cell clones was determrneo by testr;g them agaanst u;ransle;ied clF and C1R cetls pulsed wrth the resoectve peptlde (data not shown)' (c)
A2fc{tldo comfler lN) aminopropyt silica beads (4 NH2 groups/100 A2), we first prepareo an acuvated surface usrng the bis N-hydroxysuccinimide derivatrve of a diacid of oligoethyleneglycol (Fig. 4a) . The beaOs were first washed twice wrth deiontzed water, twice with ethanol, then resuspended in a small amount of anhydrous ethanol and added to a tube containing a solution of 10 mM bis(NHS)oligoethyleneglycoldicarboxylic acid (a mixture of diesters contatning seven to 14 etnyleneglycol units) ano 10 mM triethyl amtne in anhydrous drmethyl formamide. The reaction tube was inverted gently (for mixrng) for 24 h at room temperature. The beads were then wasneo three trmes with deionized water and modrfied in one of two ways: (i)The activated beads were converted into non-interacttng control beads by reacting them as above with 10 mM amtnoethanol, yielding a OH-terminated oligoethyleneglycol-derivatized surface. lt has been shown prevlously that surfaces
(.) . Schematic represenratton oi beads covalently modilied with HLA-A2 peptrde complexes and FACS analysls HLA-peplide complexes ,u"-r" io*rJnty corpred to 5lm srtica oeioidenvatized with actve (NHS) ester orouos at the temrnal posmdns ol oligoethylensgtycol {seven to 14 EG orougs per chain). The drstnbutron ol potentrally reactlve e'amrno grouoiol.lysne residues oilhe HlA-A2__peptide complex is shown on tt" ,lg;t. fh" bornons ol the tysrnes were rdentrlied usrng 15e structure ol lhe HLA-A2 peptide comptex deposrled in the ptotein data banK iili "rii"L,v"t,i-rir;g ouanta. HLA-A2 peptrde-coaled beads wefe prepared lor FAcs analvsrs exaclly as were the cells These beads (5x105) were lncubalecl wrth a porycronat ,"bb't serum (11200) agalnst heavy chatn (b) and_1 ltg ot HLA-A2-soecrfiC mAb MA2 1 (c) ano ii"in"o'r",rn irrc-go"t anrr+auoit Fiab)zlrag-"nt. 1"otid tin", b) aino goat anir-mouse F(ab)z kagments (solid.line. c) ,
Beads harborrng onlv a OH-lermrnared olrgoetny€negtycor wlre useo as a negatNe control ano slarned as deacrrbed above (dashed line in b and c) The lluorescence Inlensity oi c1R ce s wrth r;c;i-J rulic ir""ir "rpression (HLA-B.C) starned with polyclonal rabbrt serum-('l-:2OO) against heavv chain is srmrlar to (b) (data not shown) r04 ',03 ro2 rol roo t04 ,03 ''ot .,00 modrfied covalently with short oligoethyleneglycols are often highly resistant to protein adsorptron (17).
(ii) The activated beads were reacted with either the A2-RT peptide complex or the A2-gag peptide complex usrng -50 pg of either of the A2-peptide complexes (1 nmol) dissolved in PBS (1.5 mi) with 'l mM triethylamine. Approxrmately 3 mg of the actrvated beads (10 nmol) were useo per reactton mrxture. ASSumrng a maximum COVerage ol i complex/3g nmz, at most 0.1 nmol of protein would form a monolaver on the sudace of 3 mg beads; therefore, the protetn was added at 1O-fold molar eXceSS over reactrve groups in the reaction. The solution was allowed to tnvert gently for 6 h at room temperature and the beads were washed as described above. They were finally Stored at 4"C in PBS. Flg. S-Ouantrtation ol Gag-SLg-and RT-lvg-specric CTL strmulated bymultivalenl recombinant HLA'A2 peptrde complexes' Limiting dilullon "ni'r,, n lr p"Ao,."O oi pgpl6 lrom tl,iee ilv-l-rnfecled sublects. eAUC lZSO-l OOOO per well. 24 wells Aach) were stimulated rh vitto wth HLA-A2 Deotrde complexes covalenlly anached to beads {15.OOO HLA-A2 SLg beads or HLA-A2 lvg betds) and alternatvely w$ peplroepulsed {SLg or lvg) l-rr.adrated autologous PBMC of ceptrde-pulsed trrraoraled CIR'A2 translectanls (10 Fg/ml lor t h} lL'2 was added al liig "i" i,n"r concenrrarron of so U/;t The srrmurareo cTL were rested 12 days later against srcr-labeled auloiogous B-LCL alone ia) or ir-riotogous a-rcr incubaled wft 1 pg/ml sLg (c) or lv9 (O) peptlde. Fleg.essron lrnes were calculated by the melhod ol maximum lrkelrhood fr dl n'ou""t "orp"nson ot limrring dlluro; aniryies oeaormeo w'th HLA:A2 geptrde-coated beaos (a) and pepttde-pulsed autologous PBMc ioj'i" ano*n lor subjecl 15760. precu,st, irequenc,"s oi CTL delermrneo In tnree suoiecte are summanzed below Sanges are grven In parenlhesrs.
be 1QQ-fold below the minimum concentratron reqUlre6 to Stimulate the corresponding T cells wnen aoded to these cells in the presence of feeder cells.
FACS staining of A2'pepttde-coated beaos A2-oeptrde-coated beaOs were prepareo for FACS analysis exactly as were cells. Beads were washec In cold RPMI and aliquots of 5x10s beaOs were incubateo In a total voiume of 100 pl for 30 min with a polycional raobrt serum (1:200) against HLA heavy charns or wrth A2-specriic mAb MA2' 1 (1 pg), lvashed, and finally starneo wrth FITC-goat antirabbit F(ab)z fragments or goat antr-mouse F(ab)z fragments (Jackson) for 30 min at 4"C. Beacjs harborrnQ only the OHterminated oligoethyleneglycol chain were useO aS a negatlve control and Stained as described above. FACS analysis was performed as with cells.
Limiting ditution analysis of precursor CTL (O,Cfq silmulatton by recombrnant A2-peptide complexes on {nQrospheres Numbers of pCTL specific for peptides frcm the HIV-1 gag (sL9) and RT (lvg) proteins were determined by ltmitrng drlution analysis (18). Peripheral blood mononuclear cells (PBMC) from HIV-1-posrtive subjects were stimulated in vrtro usrng srlica beads to which A2-peptide complexes were covalenily attached. PBMC vrere cultured at 250 -16,000 cells/well tn 24 replicate lvells in 96-well microtrter plates (costar, cambridge, MA) with erther 15,000 beads/well coateo with A2-peptrde, aiternatlvely the PBMC were Stimulated wrth 25,000 peptrde-pulsed autologous antigen-presentrng celis [y-irradiated (3000 rad) PBMC pulsed with 10 [g/ml peptroe for t h foilowed by removal of unbound peptidel To eacrr well was added 2.5x 10a y-irradiated (3000 rad recombrnant lL-2 (50 U/ml added on day 3) After 12 days each weil was split and assayed for cytotoxtcity on slcrlabeled autologous B-LCL that were either Incubated with synthetic SL9 or lV9 peptide (1 pg/ml peptrde for t h and washed) or B-LCL without added peptrde. The fractron of non-responding wells was the number of wetls in which slCr release did not exceed the mean + 3 SD of the release In the 24 control wells (no peptide) divided by the total number of assayed wells (19, 20) . pCTL freeuency was estrmated by the maxrmum likelihood method (18).
T cell stimulation by recombinant Hl-A-peptide complexes PBMC (20,000/well) from HIV-1-positive subiect 15760 were placed in 96-well mtcrotiter plates along wrth the 5 pm stlica beads (20,0004,,/ell) modified covalently wrth the A2-peptrde complexes tn the presence or absence of 1-irradiated HLAmismatched feeder cells (3000 rad, 7x t04/well). lL-2 (Hoffman La Roche) was added at day 3 at a f inal concentratron of 50 U/ml. After 12 days lytic actrvrry was assayed on peptide-pulsed slcr-labeled target cells (autologous B-LCL pulsed wrin 1 Fg/ml peptide as descrrbeo above).
Results
Refolding of HIA-A2 in the presence of HIV-1-derived pepttdes HLA-A2 complexes with RT-lvg (A2-lV9) and Gag-Slg (A2-SL9) were formed by dilution of recombinant heavy chain (1 pM) and p2-microglobulin (2 pM) in the presence of each peprrde (100 pM) (2) . The complexes appeared as sharp peaks on HPLC gel f iltration at €lutron times consistent wrth the mot wt of the ternary complex (Fig. 1) . HPLC fractions were plpened onto nitrocellulose and stained with mAb specrfrc for ciass I MHC proterns (MHC l) The first peak fractron, corresponding to the folded complex, was recognized by mAb W6/32 (11), whrch recognrzes human MHC I molecules in general, and by'mAb PA2.1 (12) , whictr recognrzes the natrve HLA-A2 molecule specifically Thdrecognition by mAb sensttrve to conformatron rmplies that the recombinant complexes contain native epitopes, consrstent with the presence of correctly folded molecular complexes.
Adsorptton of A2-peptide complexes to target cells
To determine if the A2-peptide complexes assembled in vrtro can activate Az-restricted T cell clones, we coated a panel of A2-negatrve cells with the complexes and used them as targets for RT-|V9 and Gag-SL9 specrfic T cell clones derrved from HIV-1-infected individuals (clone 68462: antt-A2-lvg ano clone D23: anti-A2-SLg) in cytotoxrc T cell assays The moorfiecj target cells were the Ht-A-A negative human B cell line C1R (21), the MHC Inegatrve numan cell line K562, ano P815, a mouse mastocytoma cell lrne. To bind the A2-peptrde complexes on these cells, we first covalently attached the A2-soecrfic mAb MA2.1 (14) to the surface of dithiothrertoltreated C1R and PB15 cells using the heterobifunctional crosslinker SPDP. The antibody coated cells were subsequently incubated with a saturating concentration of soluble A2-ndlrtion of crL peptide comptexes. The binding of A2 to the cell surface was demonstrated byflowcytometry, using mAb B87'7 (16)' which reacts wrth a combinatorial determlnant of H|'-A-A,B,C heavy chain ano p2-microglobulin (Fig. 2) . specific lysis of A2-peptide-coated target cells by cTL clones.
As shown in Fig. 3 , the cTL ctones lysed c1R cells coated with the relevant A2-peptide complexes. rndicatrng that the Hlv-1 pepttdes were effectively presenteo and recogntzed by T ceils bearing receptors of the approprrate specificiry. ClR cells coated with the reconstituted A2'pepttde complexes were lyseo essentially as rvell aS were C1R cells transfected with A2 and pulsed with peptides (1 pg/ml)' Both T cell clones also lysed the murine P815 cells to whrch the approprrate A2-peptide complex had been adsorbed. although to a lesser extent than human target cells modrfieo wrth the same complexes. As expected. the T cells farled to lyse unrrrodrfied P815 cerls and c1R-A2 transfectants pulsed wtth an irrelevant pePtide.
Recognrtion of A2-peptide complexes by TCR was evidently not imparred by the binding of these complexes to mAb MAz.1, even though this antibody brnos to the polymorphtc regron of HI-A-A2 close to the peptrde brnding groove (22)' HLq-nz peptide molecules held by mAb MA2.1 at the cell surface mrght not be accessrble for optrmal engagement with the TCR. Accordingly mAb BBM1, an anti-p2-microglobulin antibody (13) , was covalently linked to C1R, K562 and P815 ceils. and used to bind refolded complexes. A2-peptide complexes on each of these target cells were iust as susceptible to lysrs (Fig. 3c) as target cells that made use of the MA2.1 mAb.
Covalent coupling of A2-peptide complexes to mrcrospheres. Acrucia|questioniswhethertherecomb|nantmoiecu|escan stimulate pCTL present in blood samples of HIV-1-seropostttve sublects, i.e. in naturally prrmed indrvrouals. To examtne this possrbility, we covalently coupled the A2-peptrde complexes to silica beads derivatized wrth actlve ester groups at the free ends of olrgoethyleneglycol charns tnat extenoed -3O-50 A from the bead surface. Figure 4 shows the coupling proceoure ano the dlstrlbutton of potenttally reactive e-amrno groupS of lysrne resrdues of the A2-peptrde complex. The partrcular amtno groups that react with acttvated ester groups on tf'le surface of the bead determrnes the orientatton of the MHC complex. Positive staining rvrth 3 rabbit serum against human heavy chain (Fig  4b) showed attachment of HLA complexes on the surface. Stainrng wrth the anti-Ht-A-A2 mAb MA2 1 (Fig 4c) indtcated that a srgnificant fraction of the HLA-peptrde complexes matntaineo a native configuration and were exposed to the solvent, and are thus presumably accessrble to TCR on T cells.
Recombtnant HlA-pepttde complexes are rmmunogenic To assess the immunogentc effectrveness of the A2-pepttde complexes on beads, we used them to sttmulate PBMC of three seroposrtrve sublects (161J, 1151 and 15760) measuring the frequency of peptrde specific pCTL after 12 days by limiting orlution analyses (Fig. 5) . The resuits show that the 1.ecorntinant A2-peptide complexes were effective and as specific as pepttde-pulsed autologous antrgen-presentlng responses by recombinant HU-A2 peptide complexes 107 cells in inducing functional responses that normally depend upon ceil<ell interactions, i.e. they triggered antigen{epend-ent responses of primed pCTL. A direct comparison of limiting dilution analyses performed with A2-peptide complexes displayed on beads (Fig. 5a ) and autologous peptide-pulsed PBMC (Fig. 5b) revealed that the responses were of comparable magnitude.
Expansion of pCTL is peptide specific
To rule out non-specific mitogenlc effects of the bead surface, PBMC were stimulated with a mixture of A2-lV9-and M-sL9-coated beads and tested for A2-lv9-and M-sL9-specific responses (Fig. 6) . Only SL9 specific responses were detectable. culture of the same PBMC with beads bearing only A2-lV9 induced no response; only A2-sL9 beads stimulated a specific SL9 response. The apparent absence of lV9-specific pcTL in the responder population was confirmed using the same batch of beads as in the limiting dilution analysis (Fig. 5) . The recovery of SL9-specific CTL suggests a true expansron of peptrde-specrfic pcTL, confirming other data (6 and unpublished) , that the dominant Gag-specific HLA-A2 restncted response is directed against the SL9 peptide in these subjects.
Titratron of peptide revealed that a peptide concentration over 5 ng/ml SL9 was requrred to stimulate pcTL expansion from PBMC in the presence of feeder cells (Fig. 6 and data not shown). By contrast much less peptide is needed when it is presented by HI-A-A2 on the microspheres. Thus with maximal packrng a 5 pm microsphere could accommodate about 2x 106 HLA-A2 peptrde complexes in a monolayer. This numoer corresponds to 0.35 ng/ml peptide if all the A2 on the beads were loaded with the peptide originally and all the peptrde adduct then dissociated (given 2X 101 beads, 0.2 mll well and a maxtmum of 2x103M-peptide Complexes per beao) By comparing the fluorescence intensity of HLA-A2 oeotide-coated mtcrosoheres with C1R cells stained wrth polyclonal antrbodres to MHc I heavy chain it appears, however, that the actual amount of surface-bound A2-pepttde complexes on the pnrcrospheres is -50 ttrqes lower than the calculated maxtmum. re. the fluorescence intensity ts stmtlar to C1R cels vrith -3x104 HLA 835 and Cw4 per cell (21) Thus rt appears that the T cell response was elicited by far less peptide associated wrth H[-A-A2 on the microspheres than by pepttde addeo rn solution. Non-specific mrtogenrc effects of the beads modrfied wrth only OH-terminated oligoethylenglycol groups were not observed (Fig' 6)' ,.
Discussion
This is the first demonstratron of biological activity of E' co1-derrved HLA-A2 peptroe complexes' In contrast to nattve HLA-A2, the recombrnant protern used here ts not glycosylated at Asn-86 and its p2-mrcroglobulin subunit has an aodrtional N-termrnal methionrne resrdue not cleaved follOwing synthesrs (3). These differences have previously been shown not to significantly affect the crystal structure of A2 in the form of A2-peptide complexes (3'4). We show here that these differences also do not prevent recombinant A2-Oeptrde complexes from eliciting spectfic cytolytic responses of CDB* CTL clones from HIV-1-infected 1OB tnduction of CTL responses by recombinant HtA-42 peptide complexes individuals. Thus, the antigen-specrfic receptor (TCR)of these clones can recognize recombinant E. colr-produced A2' proteins refolded in assoctation wrth approprlate peptides' This study shows furthermore that mtcrospheres coated with recombinant A2-peptide complexes can specifically stimulate T cells in PBMC from HIV-1-infected indivrduals. The stimulated cells, presumably primed by natural infectron, develop into an expanded population of CTL that specrfically responds to the A2-peptide complex that trlggered this development. Since the Az-peptide-coated microspheres lack B7 and other co-stimulatory molecules, their immunogentciN has to be considered in the light of the large body of evrdence that, in addition to TCR ligation, the actrvation of quiescent T cells depends upon secondary signals that trrgger the expressron of lL-2 receptors and the production of lymphokrnes (35) . In the present system which makes use of PBMC from HIV-1-rnfected individuals, it is possrble that the responding T cells already express lL-2 receptors and that the exogenous recombrnant lL-2 substrtutes for endogenous production of lymphokines. In addition, the HLA-mrsmatched feeder cells might provide a co-strmulatory functron and, by eliciting an alloreactron, tnduce cells in the respondrng PBMC population to produce endogenous lymphoktnes. In any event, wnatever the detailed mechantsm may be, rt seems clear that the beads coated covalently with A2-peptrde complexes are active immunogenically with PBMC of HIV-1-infected individuals.
Several drfferent systems have been developed for stimulating T cells wrth purified class I MHC molecules (24) (25) (26) including allogeneic MHC proteins (27. 28) and various methods have been used to assay T cell actlvation, e.g. release of BlT-esterase (29) , production of lL-2 in T cell hybridomas and release of serotonrn in basophils transfected with a TCR-( fusion (30) . The MHC-peptide complexes used in these studies included purrfied native MHC I molecules, cleaved from the cellular surface (28, 29) , and 'empty' MHC I molecules produced in rnsect celis and loaded with peptides of interest (31, 32) . Soluble H-2Ko-peptrde fusrons were also produced in which heavy charn, p2-mrcroglobulrn and peptide have been fused Into a single cnaln protetn and cells expressing these constructs were shown to be highly immunogenic (33) . Genetically engrneered soluble H-zOd molecules coated on plastic were also found to present HIV-1 envelope peptide to an antigen-specrfic CTL clone, inducing it to produce IFN-y (3a). Since the overexpression of the class I subunrts in the E. coli system and the subsequent refolding provides an abundant source of homogenous Ht-A-peptide complexes, the recombinant soluble complexes descrrbed here offer new tools for exploring drverse problems and tssues, such as slgnal transductron events elicited by agonrst and antagonrst peptide ligands (36, 37) , the identificatron ancj isolation of antigenspecific T lymphocytes ln complex cell mixtures, and the development of vacctnes aimed at sttmulattng partlcular anttgen-speofic T cells.
